Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024BMJOpen Access

4CPS-037 Integration of the pharmacist in the multidisciplinary committee of uro-oncological pathology

View Full Paper
Ask AI
Bookmark
Share

Authors

LMLoreto Martinez‐DueñasARA Martín RoldanYCY Salmeron Cobos

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Martinez‐Dueñas et al. (2024) studied this question.

synapsesocial.com/papers/68e7692cb6db6435876df1a8https://doi.org/10.1136/ejhpharm-2024-eahp.141
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Integrating pharmacists into uro-oncology care: Evaluation of patient satisfaction and well-being.2026 · 1 citations
  2. 2Impact of the integration of remote clinical oncology pharmacists into routine precision medicine workflows on biomarker testing rates within The US Oncology Network community-based practices.2024
  3. 34CPS-200 Triple therapy for metastatic hormone-sensitive prostate cancer patients based on a pharmacological treatment algorithm2024 · 1 citations
  4. 44CPS-097 Real-world study of apalutamide treatment in patients with metastatic hormone-sensitive prostate cancer in nine hospitals of Valencian Community2024
  5. 5Therapeutic Alliances for Optimizing the Management of Patients with Prostate Cancer: SOGUG Multidisciplinary Expert Panel Recommendations2025 · 3 citations